No abstract available
MeSH terms
-
Angiogenesis Inhibitors / adverse effects
-
Angiogenesis Inhibitors / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Aspirin / administration & dosage
-
Aspirin / therapeutic use
-
Bevacizumab
-
Hemorrhage / chemically induced
-
Humans
-
Hypertension / chemically induced*
-
Hypertension / drug therapy
-
Intestinal Perforation / chemically induced*
-
Intestinal Perforation / surgery
-
Neoplasms / drug therapy
-
Proteinuria / chemically induced*
-
Thromboembolism / chemically induced*
-
Thromboembolism / drug therapy
Substances
-
Angiogenesis Inhibitors
-
Angiotensin-Converting Enzyme Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Aspirin